• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew John Phillips

Location
Boston, MA
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew John Phillips and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Andrew John Phillips has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Enliven Therapeutics, Inc. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew John Phillips

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ELVN Enliven Therapeutics, Inc. Director 06 Feb 2025
MLTX MoonLake Immunotherapeutics Director 05 Jun 2025
OKUR OnKure Therapeutics, Inc. Director 28 May 2025

Insider Transactions Reported by Andrew John Phillips:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored